Wellington Management Group LLP Purchases 775 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Wellington Management Group LLP boosted its position in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 12.6% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,902 shares of the company’s stock after buying an additional 775 shares during the quarter. Wellington Management Group LLP’s holdings in Henry Schein were worth $478,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. MML Investors Services LLC boosted its holdings in shares of Henry Schein by 5.1% during the third quarter. MML Investors Services LLC now owns 11,000 shares of the company’s stock worth $802,000 after purchasing an additional 535 shares during the period. Barclays PLC raised its position in Henry Schein by 6.9% during the 3rd quarter. Barclays PLC now owns 286,475 shares of the company’s stock valued at $20,882,000 after purchasing an additional 18,458 shares during the last quarter. M&T Bank Corp lifted its holdings in Henry Schein by 4.5% in the 3rd quarter. M&T Bank Corp now owns 10,990 shares of the company’s stock worth $802,000 after buying an additional 472 shares during the period. Virtu Financial LLC bought a new stake in shares of Henry Schein in the 3rd quarter worth approximately $239,000. Finally, Wilmington Savings Fund Society FSB bought a new stake in shares of Henry Schein in the 3rd quarter worth approximately $109,000. Hedge funds and other institutional investors own 96.62% of the company’s stock.

Wall Street Analyst Weigh In

HSIC has been the subject of a number of research analyst reports. Wells Fargo & Company assumed coverage on Henry Schein in a research note on Friday, February 14th. They issued an “equal weight” rating and a $80.00 price target for the company. Bank of America raised shares of Henry Schein from an “underperform” rating to a “buy” rating and raised their target price for the stock from $69.00 to $84.00 in a research report on Monday, January 6th. UBS Group reduced their price target on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating on the stock in a research report on Wednesday, February 26th. Barrington Research restated an “outperform” rating and issued a $90.00 price objective on shares of Henry Schein in a report on Wednesday, February 26th. Finally, StockNews.com raised Henry Schein from a “hold” rating to a “buy” rating in a research report on Wednesday, April 9th. Five investment analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $81.10.

Henry Schein Stock Performance

Shares of HSIC opened at $65.61 on Tuesday. Henry Schein, Inc. has a 52 week low of $60.56 and a 52 week high of $82.49. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. The stock has a market cap of $8.15 billion, a P/E ratio of 27.00, a P/E/G ratio of 2.13 and a beta of 0.84. The business’s 50 day moving average price is $71.58 and its 200-day moving average price is $72.19.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company’s revenue was up 5.8% compared to the same quarter last year. During the same period last year, the firm posted $0.66 earnings per share. Equities research analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current fiscal year.

Insider Buying and Selling at Henry Schein

In other news, CEO Bradford C. Connett sold 4,036 shares of the stock in a transaction that occurred on Wednesday, March 19th. The shares were sold at an average price of $71.15, for a total transaction of $287,161.40. Following the sale, the chief executive officer now owns 62,688 shares in the company, valued at $4,460,251.20. This represents a 6.05 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Philip A. Laskawy sold 2,604 shares of the business’s stock in a transaction that occurred on Wednesday, March 19th. The stock was sold at an average price of $71.04, for a total transaction of $184,988.16. Following the completion of the transaction, the director now owns 24,805 shares of the company’s stock, valued at approximately $1,762,147.20. The trade was a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is owned by company insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.